Lars Christian M.
- Country
- Denmark
- Department
- Dept of otorhinolaryngology
Research Overview
- Treatment of rhinosinusitis with nasal polyposis with dupilumab and mepolizumab: A randomized, multi-centre, head-to-head comparison in real-world Danish patients
- Evaluation of Mepolizumab and Dupilumab Discontinuation in Achieving Sustained Remission in Severe Chronic Rhinosinusitis with Nasal Polyps: A Danish RCT
- Evaluation of Biologic Tapering with Mepolizumab and Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps: A Danish RCT
Data & Insights
Has run more than one trial at 8 of 12 partner sites.
Specializations
Rhinology Research
This investigator specializes in the treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP), with particular emphasis on biological therapies and their long-term management.
- Biological Treatment Efficacy
- Treatment Optimization
- Disease Control Assessment
The research focus includes comparative analysis of different biological agents in treating nasal polyposis.
Therapeutic Innovation
The investigator explores innovative approaches in monoclonal antibody treatments, specifically studying treatment discontinuation strategies and long-term outcomes in patients with nasal polyps.
- Remission Studies
- Treatment Duration Assessment
- Symptom Recurrence Prevention
Research interests extend to evaluating sustained disease control after biological therapy.
Clinical Management
Expertise in developing treatment tapering protocols for patients with chronic rhinosinusitis, focusing on optimizing biological therapy dosing intervals.
- Long-term Disease Management
- Dosing Strategy Optimization
- Treatment Response Monitoring
The investigator studies sustained disease control in patients with established treatment response.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.